Upstream Bio (UPB) Other Operating Expenses (2024 - 2026)

Upstream Bio's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 5.6% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was -$4.6 million, a 77.37% decrease from a year earlier, with the FY2025 full-year figure at -$4.5 million, down 127.77% from the prior year.
• Other Operating Expenses improved to -$1.1 million in Q1 2026 per UPB's latest filing, from -$1.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at -$334000.0 in Q2 2024 and bottomed at -$1.3 million in Q4 2025.
• The 3-year median for Other Operating Expenses is -$891000.0 (2025), against an average of -$843666.7.
• Across the five-year window, Other Operating Expenses plunged 273.95% in 2025 and retreated 5.6% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at -$836000.0 in 2024, then slumped by 56.58% to -$1.3 million in 2025, then grew by 14.97% to -$1.1 million in 2026.
• Per Business Quant, the three latest UPB Other Operating Expenses figures stand at -$1.1 million (Q1 2026), -$1.3 million (Q4 2025), and -$891000.0 (Q3 2025).